Abstracts featured at AUA21

The AUA2021 was held virtually virtually on September 10-13.

Found below is the list of prostate cancer-related AUA2021 abstracts that caught attention of our editorial board!

• Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
  Francesco Barletta et al.
• What is the Definition of Misclassification in Patients with Grade Group 2 prostate cancer Eligible for Active Surveillance and diagnosed with MRI targeted biopsy? A multi-institutional analysis with pathological confirmation
  Giorgio Gandaglia et al.
• Urethral fixation: a novel technique to improve early urinary continence recovery after robot-assisted radical prostatectomy
  Vincenzo Ficarra et al.
• Cumulative Androgen Deprivation Therapy Exposure for Prostate Cancer is Associated with an Increased Risk of Dementia
  Peter E Lonergan et al.
• Pembrolizumab (Pembro) Plus Olaparib in Patients With Docetaxel-Pretreated Metastatic Castration-Resistant Prostate Cancer (mCRPC): Updated Results From KEYNOTE-365 Cohort A With a Minimum of 11 Months of Follow-Up for All Patients
  Luke T. Nordquist et al.
• Significant inter- and intra-laboratory variation in Gleason grading of prostate cancer: a nationwide study of 35,258 patients in The Netherlands
  Rachel Flach et al.
• Assessing The Need For Systematic Biopsies In Addition To Targeted Biopsies According To The Volume Of The Index Lesion Diagnosed At Mpmri. Results From A Large, Multi-Institutional Database
  Francesco Pellegrino et al.
• Influence of Sociodemographic Factors on Definitive Intervention Among Very Low- and Low-Risk Active Surveillance Patients
  Rashid Sayyid et al.